Efficient synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methylbenzyl)hexahydro-1,4-diazepine, I

被引:0
作者
Harada, H [1 ]
Morie, T [1 ]
Kato, S [1 ]
机构
[1] Dainippon Pharmaceut Co Ltd, Discovery Res Labs 1, Suita, Osaka 5640053, Japan
关键词
(R)-6-aminohexahydro-1,4-diazepine; DAT-582; (S)-2,3-diaminopropyl-aminoacetate; intramolecular reductive cyclization;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An efficient and practical method for large scale synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methyl benzyl)hexahydro-1,4-diazepine (R-3), which is a key intermediate in the synthesis of DAT-582, a potent and selective serotonin-3 receptor antagonist, is described, The precursor of R-3, the (S)-2,3-diaminopropylaminoacetate S-5, was obtained from the chiral triaminopropane derivative R-19. Nucleophilic reaction of the chiral mesylate R-ll with 3-methylbenzylamine gave the racemic 2,3-diaminopropylaminoacetate (+/-)-5 vie the achiral azetidinium cation 12, while the reaction of the N-protected mesylate R-14 produced the desired triamine S-15 but in poor yield, However, reaction of the N-protected mesylate S-18 with a large excess of methylamine proceeded smoothly to afford R-19 in good yield. S-5 was converted into R-3 with >99% enantiomeric excess using an intramolecular reductive cyclization method.
引用
收藏
页码:1160 / 1164
页数:5
相关论文
共 19 条
[1]   NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY [J].
ANDREWS, PLR ;
RAPEPORT, WG ;
SANGER, GJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) :334-341
[2]   ENANTIOSPECIFIC SYNTHESIS OF D-ALPHA,OMEGA-DIAMINOALKANOIC ACIDS [J].
BEAULIEU, PL ;
SCHILLER, PW .
TETRAHEDRON LETTERS, 1988, 29 (17) :2019-2022
[3]  
COSTALL B, 1987, British Journal of Pharmacology, V90, p89P
[4]   EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :881-894
[5]   THE PSYCHOPHARMACOLOGY OF 5-HT3 RECEPTORS [J].
COSTALL, B ;
NAYLOR, RJ ;
TYERS, MB .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) :181-202
[6]   PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST [J].
CUNNINGHAM, D ;
POPLE, A ;
FORD, HT ;
HAWTHORN, J ;
GAZET, JC ;
CHALLONER, T ;
COOMBES, RC .
LANCET, 1987, 1 (8548) :1461-1463
[7]  
Harada H, 1996, CHEM PHARM BULL, V44, P2205
[8]  
HARADA H, 1997, J CHEM SOC P1, P3219
[9]   THE POTENTIAL ANXIOLYTIC ACTIVITY OF GR38032F, A 5-HT3-RECEPTOR ANTAGONIST [J].
JONES, BJ ;
COSTALL, B ;
DOMENEY, AM ;
KELLY, ME ;
NAYLOR, RJ ;
OAKLEY, NR ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :985-993
[10]   SYNTHESIS OF 6-AMINO-1-BENZYL-4-METHYLHEXAHYDRO-1H-1,4-DIAZEPINE [J].
KATO, S ;
HARADA, H ;
MORIE, T .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1995, 32 (02) :637-642